Media

Washington, D.C. — Yesterday, Congresswoman Diana Harshbarger (TN-01) reintroduced pro-life legislation that overturns Biden-era FDA policy, which allowed mifepristone, a potentially dangerous drug used for chemical abortions, to be prescribed without an in-person visit to a doctor, available via mail order. This bill will also prevent the federal government from putting a similar rule in place in the future.

The original cosponsors of the legislation are as follows:

Washington, D.C. – Today, Representatives Diana Harshbarger (R-Tenn.) and Jake Auchincloss (D-Mass.) introduced the Patients Before Monopolies (PBM) Act. This bipartisan, bicameral legislation will prohibit joint ownership of pharmacy benefit managers (PBMs) and pharmacies, a gross conflict of interest that enables these companies to enrich themselves at the expense of patients and independent pharmacies. 

Tuesday, December 10th, FEMA will be holding a webinar outlining how communities can use and benefit from public assistance through their cost-sharing assistance program. Local partners, non-profits, and community leaders are encouraged to join.

FEMA’s Public Assistance Mitigation Cost Share Incentives Webinar

Date: Tuesday, Dec. 10, 2024

Washington, D.C. - Congresswoman Diana Harshbarger (TN-01) will be hosting two upcoming 'Coffee With Your Congresswoman' events to share updates from Washington, give information on ways her office can help constituents with federal agency-related issues, and answer questions from attendees.

Constituents are encouraged to RSVP by email:

TN01.RSVP@mail.house.gov

All events are open to the press.